Cargando…

Acute Exacerbation of Idiopathic Pulmonary Fibrosis With Pirfenidone and Nintedanib: A Friend or Foe

Acute exacerbation (AE) in idiopathic pulmonary fibrosis (IPF) is unfortunate a deadly event with a very high mortality rate. Its occurrence is highly unpredictable, though few baseline risk factors have been identified. The revised definition of AE is more precise with clarity on defined parameters...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaushal, Mohit, Talwar, Dhruv, Prajapat, Deepak, Kumar, Sunil, Acharya, Sourya, Talwar, Deepak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957895/ https://www.ncbi.nlm.nih.gov/pubmed/35371648 http://dx.doi.org/10.7759/cureus.22606

Ejemplares similares

Real world efficacy and safety of nintedanib in idiopathic pulmonary fibrosis: A single center, observational study from India
por: Talwar, Deepak, et al.
Publicado: (2022)

Pulmonary-Renal Syndrome: A Real-World Experience From a Tertiary Care Pulmonary Center in North India
por: Talwar, Deepak, et al.
Publicado: (2022)

Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis
por: Flaherty, Kevin R., et al.
Publicado: (2018)

Hematological Manifestations of COVID-19 and Their Prognostic Significance in an Intensive Care Unit: A Cross-Sectional Study
por: Bawiskar, Nipun, et al.
Publicado: (2021)

Paroxysmal Supraventricular Tachycardia and Cardiac Arrest: A Presentation of Pulmonary Embolism With Infarction as a Sequela of Long COVID Syndrome
por: Talwar, Dhruv, et al.
Publicado: (2021)

Spontaneous Recovery in Complete Foot Drop in a Case of Lumbar Disc Herniation: A Neurological Surprise
por: Chandankhede, Abhijit Ravindra, et al.
Publicado: (2022)

Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis
por: Lehtonen, Siri T., et al.
Publicado: (2016)

Comparative outcomes in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis
por: Belhassen, Manon, et al.
Publicado: (2021)

Intractable Hiccups in a Young Male: Is it a Tell-Tale Sign of Pseudocyst of Pancreas?
por: Talwar, Dhruv, et al.
Publicado: (2021)

Pylephlebitis With Hepatic Abscess Complicating a Case of Acute Pancreatitis in a Young Male: Startling Complication of Intra-Abdominal Sepsis
por: Talwar, Dhruv, et al.
Publicado: (2022)

Mediastinal Eventration of a Pseudocyst of Pancreas Presenting As Acute Shock Syndrome: Expecting the Unexpected
por: Shah, Param, et al.
Publicado: (2022)

Evolution of Middle Ear Modelling Techniques: A Review
por: Parveen, Sana, et al.
Publicado: (2021)

Hyperemesis Gravidarum Presenting as Severe Hypokalemic Periodic Paralysis and Type II Respiratory Failure: A Different Form of Thyroid Storm?
por: Naik, Srinivas, et al.
Publicado: (2021)

A Curious Case of Snake Venom Addiction as an Alcohol De-Addiction Tool: Pain for Gain?
por: Talwar, Dhruv, et al.
Publicado: (2021)

Crossed Fused Renal Ectopia With Acute Pyelonephritis: A Case Report
por: Jaiswal, Praraj, et al.
Publicado: (2021)

Effectiveness and Safety of Pirfenidone and Nintedanib for Pulmonary Fibrosis in COVID-19-Induced Severe Pneumonia: An Interventional Study
por: Choudhary, Rajkamal, et al.
Publicado: (2022)

Vanishing lung syndrome masquerading as pneumothorax in a smoker: Now you see me, now you do not
por: Talwar, Dhruv, et al.
Publicado: (2022)

Cost-Effectiveness Analysis of Nintedanib Versus Pirfenidone in Idiopathic Pulmonary Fibrosis in Belgium
por: Rinciog, C., et al.
Publicado: (2020)

Differential Discontinuation Profiles between Pirfenidone and Nintedanib in Patients with Idiopathic Pulmonary Fibrosis
por: Takehara, Kazutaka, et al.
Publicado: (2022)

Atlantooccipital Assimilation and Basilar Invagination Treated Successfully in a Young Male With Marfanoid Features: A Stitch in Time
por: Mahajan, Satish, et al.
Publicado: (2021)

Pirfenidone vs. nintedanib in patients with idiopathic pulmonary fibrosis: a retrospective cohort study
por: Marijic, Pavo, et al.
Publicado: (2021)

A Case of Suprasellar, Intrasellar, and Infrasellar Meningioma Presenting as a Visual Field Defect in an Obese Female
por: Sesha Satya Sagar, Vankadari Venkata, et al.
Publicado: (2022)

Myocardial Performance Index Among Patients of Sickle Cell Disorder in Rural Teaching Hospital: A Case-Control Study
por: Chaturvedi, Anuj, et al.
Publicado: (2021)

Treatment with nintedanib for acute exacerbation of idiopathic pulmonary fibrosis
por: Tomioka, Hiromi, et al.
Publicado: (2017)

Pharmacological treatment of idiopathic pulmonary fibrosis – preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine
por: Myllärniemi, Marjukka, et al.
Publicado: (2015)

Real World Experiences: Pirfenidone and Nintedanib are Effective and Well Tolerated Treatments for Idiopathic Pulmonary Fibrosis
por: Hughes, Gareth, et al.
Publicado: (2016)

Patient expectations, experiences and satisfaction with nintedanib and pirfenidone in idiopathic pulmonary fibrosis: a quantitative study
por: Moor, C. C., et al.
Publicado: (2020)

Pharmacological Interactions of Nintedanib and Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Times of COVID-19 Pandemic
por: Serra López-Matencio, José M., et al.
Publicado: (2021)

A retrospective observational study on pheno-endotypes of severe asthma among adults attending asthma clinic in a tertiary care centre in India
por: Talwar, Deepak, et al.
Publicado: (2022)

Seronegative Autoimmune Basal Ganglia Encephalitis Presenting as Acute Parkinsonism and Refractory Faciobrachial Seizures: A Case Report
por: Giri, Anamika, et al.
Publicado: (2022)

Macrophages: friend or foe in idiopathic pulmonary fibrosis?
por: Zhang, Lei, et al.
Publicado: (2018)

Pulmonary Hypertension Exacerbated by Nintedanib Administration for Idiopathic Pulmonary Fibrosis
por: Shimomura, Iwao, et al.
Publicado: (2018)

Retrospective Analysis of Medication Utilization and Clinical Outcomes in Patients With Idiopathic Pulmonary Fibrosis Treated With Nintedanib or Pirfenidone
por: Ipatova, Anastasia Y, et al.
Publicado: (2019)

South–West of England’s Experience of the Safety and Tolerability Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
por: Barratt, Shaney L., et al.
Publicado: (2018)

Nintedanib and pirfenidone for idiopathic pulmonary fibrosis in King Abdulaziz Medical City, Riyadh: Real-life data
por: Khan, Mohammed Ayaz, et al.
Publicado: (2023)

Association of Serum High Sensitivity C-Reactive Protein With Pre-diabetes in Rural Population: A Two-Year Cross-Sectional Study
por: Ghule, Aishwarya, et al.
Publicado: (2021)

Artery of Percheron Stroke: A Case Report With a Diagnostic Challenge
por: Phate, Neha, et al.
Publicado: (2022)

Recurrent non‐traumatic idiopathic chylothorax: a diagnostic dilemma with therapeutic challenge
por: Vadala, Rohit, et al.
Publicado: (2020)

Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review
por: Amati, Francesco, et al.
Publicado: (2023)

Randomized phase II study of nintedanib with or without pirfenidone in patients with idiopathic pulmonary fibrosis who experienced disease progression during prior pirfenidone administration
por: Ikeda, Satoshi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5sn9frprob3e6t7b31leaiouvi